Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease | Journal of Medical Genetics

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via CCMG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Genotype-phenotype correlations

Original research

Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease

Online download statistics by month:

Online download statistics by month: January 2021 to April 2023

	Abstract	Full	Pdf
Jan 2021	181	173	77
Feb 2021	420	398	165
Mar 2021	267	259	109
Apr 2021	214	208	88
May 2021	172	161	70
Jun 2021	154	144	90
Jul 2021	164	151	79
Aug 2021	202	192	83
Sep 2021	158	152	91
Oct 2021	226	219	110
Nov 2021	455	435	133
Dec 2021	330	330	57
Jan 2022	160	161	66
Feb 2022	348	348	70
Mar 2022	381	369	101
Apr 2022	230	239	95
May 2022	225	221	78
Jun 2022	233	191	68
Jul 2022	176	172	46
Aug 2022	164	160	71
Sep 2022	258	249	70
Oct 2022	267	261	71
Nov 2022	261	251	61
Dec 2022	158	146	29
Jan 2023	131	114	28
Feb 2023	146	134	44
Mar 2023	166	162	42
Apr 2023	154	152	57
Total	6401	6152	2149